Company / Profit Margin
KYNTRA BIO, INC. Profit Margin History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Profit Margin
-160.6%
FY2025
5-year range
-607.3% / -30.0%
FY2021-FY2025
Trend
+73.5%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Profit Margin returned to growth in FY2025 after 3 years of decline, reaching -160.6%.
Based on SEC 10-K filings.
-160.6% in FY2025 with a 5-year CAGR of -120.1%.
Declined from -123.3% to -160.6% over the past 2 years.
Profit Margin over time
Growth rates
- 3-Year Change
- -53.3pp
- 5-Year Change
- -120.1pp
- 10-Year Change
- -
Key checks
Key Insights
- In FY2025, profit margin increased 73.5% year-over-year.
- Peak profit margin was recorded in FY2021.
- Lowest profit margin in the period was in FY2024.
Company context
Key Data Points
- Altman Z-Score -3.33 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Profit MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -160.6% | +73.5% |
| FY2024 | -607.3% | -392.7% |
| FY2023 | -123.3% | -14.8% |
| FY2022 | -107.4% | -257.9% |
| FY2021 | -30.0% | +26.1% |
| FY2020 | -40.6% | +56.0% |
| FY2019 | -92.3% | -191.1% |
| FY2018 | -31.7% | +33.2% |
| FY2017 | -47.4% | -9.7% |
| FY2016 | -43.2% | -195.6% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026